Development and testing of lucid: a therapeutic device for brain injury following infant cardiac arrest - cardiac arrest in infants is a medical emergency requiring rapid resuscitation to restore…
Ended Cooperative Agreement Awarded Last action
- Award ID
- U44NS125160
- Recipient
-
Mitovation, Inc. UEI RDNAEF71R5E6
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,589,179
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Place of performance
- Michigan, USA
Award details come from USAspending.gov.
Description
Development and testing of lucid: a therapeutic device for brain injury following infant cardiac arrest - cardiac arrest in infants is a medical emergency requiring rapid resuscitation to restore circulation. However, resuscitation often results in significant brain injury, caused by ischemia/reperfusion injury. Only 36% of infants (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $99,400 | |
| Amendment | $99,400 | |
| Amendment | $986,555 | |
| Amendment | $986,555 | |
| Amendment | $417,931 | |
| Amendment | $581,407 | |
| Original award | $417,931 |
Quick answers
Who received award U44NS125160?
U44NS125160 was awarded to Mitovation, Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 21, 2022.
How much is award U44NS125160 worth?
$3,589,179 has been obligated on U44NS125160.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award